日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unveiling the immune landscape and microenvironmental architecture of IgA nephropathy using single-cell imaging mass cytometry

利用单细胞成像质谱流式细胞术揭示IgA肾病的免疫图谱和微环境结构

Chen, Xing; Liu, Long; Yao, Lijing; Shen, Jianxin; Zhang, Hengyuan; Shao, Leping; Yu, Xingxing; Lin, Zhijuan; Zhang, Lu

A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma

基于机器学习的滤泡性淋巴瘤POD24预测模型:中国滤泡性淋巴瘤研讨会的一项研究

Zha, Jie; Chen, Qinwei; Zhang, Wei; Jing, Hongmei; Ye, Jingjing; Liu, Huanhuan; Yu, Haifeng; Yi, Shuhua; Li, Caixia; Zheng, Zhong; Xu, Wei; Li, Zhifeng; Lin, Zhijuan; Ping, Lingyan; He, Xiaohua; Zhang, Liling; Xie, Ying; Chen, Feili; Sun, Xiuhua; Su, Liping; Zhang, Huilai; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing

Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer

HMGA与非编码RNA之间复杂的相互作用调控癌症的特征。

Zhang, Lijie; Zhao, Xiaomin; Gao, Xianghong; Qin, Hao; Chen, Feng; Lin, Zhijuan

LINC02266 promotes proliferation and metastasis and inhibits ferroptosis of gastric cancer cells by regulating AKT/ACSL4 pathway.

LINC02266 通过调节 AKT/ACSL4 通路促进胃癌细胞增殖和转移,并抑制其铁死亡。

Liang Xiaoru, Niu Xinyu, Zhang Lijie, Liu Chang, Zhao Xiaomin, Chen Feng, Lin Zhijuan

Integration of PET/CT parameters and a clinical variable to predict the risk of progression of disease within 24 months (POD24) in follicular lymphoma

整合PET/CT参数和临床变量预测滤泡性淋巴瘤24个月内疾病进展风险(POD24)

Jiang, Qiuhui; Lin, Zhijuan; Chen, Qinwei; Lin, Feng; Jiang, Chong; Deng, Manman; Zha, Jie; Liu, Long; Ding, Chongyang; Xu, Bing

Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma

维奈托克治疗髓系肉瘤患者的真实世界经验

Jian, Xinyi; Cha, Jie; Lin, Zhijuan; Xie, Siting; Huang, Yueting; Lin, Yun; Zhao, Haijun; Xu, Bing; Luo, Yiming

Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting

双特异性抗体单药或联合疗法治疗非霍奇金B细胞淋巴瘤:美国血液学会2022年年会最新进展

Lin, Zhijuan; Liu, Long; Li, Zhifeng; Xu, Bing

Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study

3a级和1-2级滤泡性淋巴瘤患者临床特征和预后的差异:一项真实世界多中心研究

Zha, Jie; Chen, Qinwei; Ye, Jingjing; Yu, Haifeng; Yi, Shuhua; Zheng, Zhong; Xu, Wei; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Zhang, Liling; Li, Caixia; Xie, Ying; Chen, Feili; Sun, Xiuhua; Su, Liping; Zhang, Huilai; Fan, Liyuan; Lin, Zhijuan; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing

Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling.

Orelabrutinib 和 venetoclax 通过干扰 PI3K/AKT 和 p38/MAPK 信号通路之间的串扰,协同诱导双重打击淋巴瘤细胞死亡

Pan Guangchao, Zhong Mengya, Yao Jingwei, Tan Jinshui, Zheng Huijian, Jiang Yuelong, Tang Yuanfang, Zhou Hui, Qin Dongmei, Yu Xingxing, Liu Long, Li Zhifeng, Lin Zhijuan, Jiang Yirong, Xu Bing, Zha Jie

Nutrition knowledge, attitudes, and dietary practices among parents of children and adolescents in Weifang, China: A cross-sectional study

中国潍坊市儿童和青少年父母的营养知识、态度和饮食习惯:一项横断面研究

Ma, Lirong; Xu, Huasheng; Zhang, Zhuoran; Li, Liyang; Lin, Zhijuan; Qin, Hao